Prevention of cytomegalovirus disease in transplant recipients.
Snydman
D R
DR
Falagas
M E
ME
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000517:prevention & control* / Q000635:transmission; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D016377:Organ Transplantation / Q000009:adverse effects*; D014019:Tissue Donors
D000961:Antilymphocyte Serum; D000998:Antiviral Agents; D015774:Ganciclovir